1 Cancer Drug Therapy Market Overview
1.1 Product Overview and Scope of Cancer Drug Therapy
1.2 Cancer Drug Therapy Segment by Type
1.2.1 Global Cancer Drug Therapy Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Targeted Therapy
1.2.3 Chemotherapy
1.2.4 Immunotherapy
1.3 Cancer Drug Therapy Segment by Application
1.3.1 Cancer Drug Therapy Sales Comparison by Application: (2021-2027)
1.3.2 Angiogenesis Inhibitors
1.3.3 mTOR Inhibitors
1.3.4 Monoclonal Antibodies
1.3.5 Cytokine Immunotherapy (IL-2)
1.4 Global Cancer Drug Therapy Market Size Estimates and Forecasts
1.4.1 Global Cancer Drug Therapy Revenue 2016-2027
1.4.2 Global Cancer Drug Therapy Sales 2016-2027
1.4.3 Cancer Drug Therapy Market Size by Region: 2016 Versus 2021 Versus 2027

2 Cancer Drug Therapy Market Competition by Manufacturers
2.1 Global Cancer Drug Therapy Sales Market Share by Manufacturers (2016-2021)
2.2 Global Cancer Drug Therapy Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Cancer Drug Therapy Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Cancer Drug Therapy Manufacturing Sites, Area Served, Product Type
2.5 Cancer Drug Therapy Market Competitive Situation and Trends
2.5.1 Cancer Drug Therapy Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Cancer Drug Therapy Players Market Share by Revenue
2.5.3 Global Cancer Drug Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Cancer Drug Therapy Retrospective Market Scenario by Region
3.1 Global Cancer Drug Therapy Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Cancer Drug Therapy Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Cancer Drug Therapy Market Facts & Figures by Country
3.3.1 North America Cancer Drug Therapy Sales by Country
3.3.2 North America Cancer Drug Therapy Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Cancer Drug Therapy Market Facts & Figures by Country
3.4.1 Europe Cancer Drug Therapy Sales by Country
3.4.2 Europe Cancer Drug Therapy Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Cancer Drug Therapy Market Facts & Figures by Region
3.5.1 Asia Pacific Cancer Drug Therapy Sales by Region
3.5.2 Asia Pacific Cancer Drug Therapy Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Cancer Drug Therapy Market Facts & Figures by Country
3.6.1 Latin America Cancer Drug Therapy Sales by Country
3.6.2 Latin America Cancer Drug Therapy Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Cancer Drug Therapy Market Facts & Figures by Country
3.7.1 Middle East and Africa Cancer Drug Therapy Sales by Country
3.7.2 Middle East and Africa Cancer Drug Therapy Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Cancer Drug Therapy Historic Market Analysis by Type
4.1 Global Cancer Drug Therapy Sales Market Share by Type (2016-2021)
4.2 Global Cancer Drug Therapy Revenue Market Share by Type (2016-2021)
4.3 Global Cancer Drug Therapy Price by Type (2016-2021)

5 Global Cancer Drug Therapy Historic Market Analysis by Application
5.1 Global Cancer Drug Therapy Sales Market Share by Application (2016-2021)
5.2 Global Cancer Drug Therapy Revenue Market Share by Application (2016-2021)
5.3 Global Cancer Drug Therapy Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Amgen / Allergan
6.1.1 Amgen / Allergan Corporation Information
6.1.2 Amgen / Allergan Description and Business Overview
6.1.3 Amgen / Allergan Cancer Drug Therapy Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Amgen / Allergan Product Portfolio
6.1.5 Amgen / Allergan Recent Developments/Updates
6.2 Argos Therapeutics
6.2.1 Argos Therapeutics Corporation Information
6.2.2 Argos Therapeutics Description and Business Overview
6.2.3 Argos Therapeutics Cancer Drug Therapy Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Argos Therapeutics Product Portfolio
6.2.5 Argos Therapeutics Recent Developments/Updates
6.3 AstraZeneca
6.3.1 AstraZeneca Corporation Information
6.3.2 AstraZeneca Description and Business Overview
6.3.3 AstraZeneca Cancer Drug Therapy Sales, Revenue and Gross Margin (2016-2021)
6.3.4 AstraZeneca Product Portfolio
6.3.5 AstraZeneca Recent Developments/Updates
6.4 Aveo Pharmaceuticals
6.4.1 Aveo Pharmaceuticals Corporation Information
6.4.2 Aveo Pharmaceuticals Description and Business Overview
6.4.3 Aveo Pharmaceuticals Cancer Drug Therapy Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Aveo Pharmaceuticals Product Portfolio
6.4.5 Aveo Pharmaceuticals Recent Developments/Updates
6.5 Bayer
6.5.1 Bayer Corporation Information
6.5.2 Bayer Description and Business Overview
6.5.3 Bayer Cancer Drug Therapy Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Bayer Product Portfolio
6.5.5 Bayer Recent Developments/Updates
6.6 Exelixis
6.6.1 Exelixis Corporation Information
6.6.2 Exelixis Description and Business Overview
6.6.3 Exelixis Cancer Drug Therapy Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Exelixis Product Portfolio
6.6.5 Exelixis Recent Developments/Updates
6.7 Incyte
6.6.1 Incyte Corporation Information
6.6.2 Incyte Description and Business Overview
6.6.3 Incyte Cancer Drug Therapy Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Incyte Product Portfolio
6.7.5 Incyte Recent Developments/Updates
6.8 Merck
6.8.1 Merck Corporation Information
6.8.2 Merck Description and Business Overview
6.8.3 Merck Cancer Drug Therapy Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Merck Product Portfolio
6.8.5 Merck Recent Developments/Updates
6.9 Roche
6.9.1 Roche Corporation Information
6.9.2 Roche Description and Business Overview
6.9.3 Roche Cancer Drug Therapy Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Roche Product Portfolio
6.9.5 Roche Recent Developments/Updates
6.10 Bristol-Myers Squibb
6.10.1 Bristol-Myers Squibb Corporation Information
6.10.2 Bristol-Myers Squibb Description and Business Overview
6.10.3 Bristol-Myers Squibb Cancer Drug Therapy Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Bristol-Myers Squibb Product Portfolio
6.10.5 Bristol-Myers Squibb Recent Developments/Updates
6.11 Eisai
6.11.1 Eisai Corporation Information
6.11.2 Eisai Cancer Drug Therapy Description and Business Overview
6.11.3 Eisai Cancer Drug Therapy Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Eisai Product Portfolio
6.11.5 Eisai Recent Developments/Updates
6.12 Exelixis
6.12.1 Exelixis Corporation Information
6.12.2 Exelixis Cancer Drug Therapy Description and Business Overview
6.12.3 Exelixis Cancer Drug Therapy Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Exelixis Product Portfolio
6.12.5 Exelixis Recent Developments/Updates
6.13 Genentech (Roche)
6.13.1 Genentech (Roche) Corporation Information
6.13.2 Genentech (Roche) Cancer Drug Therapy Description and Business Overview
6.13.3 Genentech (Roche) Cancer Drug Therapy Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Genentech (Roche) Product Portfolio
6.13.5 Genentech (Roche) Recent Developments/Updates
6.14 Novartis
6.14.1 Novartis Corporation Information
6.14.2 Novartis Cancer Drug Therapy Description and Business Overview
6.14.3 Novartis Cancer Drug Therapy Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Novartis Product Portfolio
6.14.5 Novartis Recent Developments/Updates
6.15 Pfizer
6.15.1 Pfizer Corporation Information
6.15.2 Pfizer Cancer Drug Therapy Description and Business Overview
6.15.3 Pfizer Cancer Drug Therapy Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Pfizer Product Portfolio
6.15.5 Pfizer Recent Developments/Updates
6.16 Prometheus Labs
6.16.1 Prometheus Labs Corporation Information
6.16.2 Prometheus Labs Cancer Drug Therapy Description and Business Overview
6.16.3 Prometheus Labs Cancer Drug Therapy Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Prometheus Labs Product Portfolio
6.16.5 Prometheus Labs Recent Developments/Updates

7 Cancer Drug Therapy Manufacturing Cost Analysis
7.1 Cancer Drug Therapy Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Cancer Drug Therapy
7.4 Cancer Drug Therapy Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Cancer Drug Therapy Distributors List
8.3 Cancer Drug Therapy Customers

9 Cancer Drug Therapy Market Dynamics
9.1 Cancer Drug Therapy Industry Trends
9.2 Cancer Drug Therapy Growth Drivers
9.3 Cancer Drug Therapy Market Challenges
9.4 Cancer Drug Therapy Market Restraints

10 Global Market Forecast
10.1 Cancer Drug Therapy Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Cancer Drug Therapy by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Cancer Drug Therapy by Type (2022-2027)
10.2 Cancer Drug Therapy Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Cancer Drug Therapy by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Cancer Drug Therapy by Application (2022-2027)
10.3 Cancer Drug Therapy Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Cancer Drug Therapy by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Cancer Drug Therapy by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer